ARCHIVES

Olaparib Study Demonstrates No Changes In Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

IOM Panel Suggest Ways To Fund More Training, Construction

November 9, 1990

Avastin Loses Indication for Breast Cancer

November 18, 2011

32% Rise In Breast Cancer Diagnosis In 1980s Explained By Increase In Mammography Screening

September 21, 1990

In Brief: Foundation Gives Georgetown $2.9 Million For Pediatric Lab, To Be Headed By Cairo

February 6, 1998

NCI Cooperative Group, Cancer Center Trials Listed

March 27, 2009

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999